Cellectis (CLLS) EPS (Basic): 2014-2022
Historic EPS (Basic) for Cellectis (CLLS) over the last 9 years, with Dec 2022 value amounting to -$2.33.
- Cellectis' EPS (Basic) rose 49.75% to -$0.31 in Q3 2023 from the same period last year, while for Sep 2023 it was -$1.77, marking a year-over-year increase of 22.74%. This contributed to the annual value of -$2.33 for FY2022, which is 8.63% up from last year.
- As of FY2022, Cellectis' EPS (Basic) stood at -$2.33, which was up 8.63% from -$2.55 recorded in FY2021.
- In the past 5 years, Cellectis' EPS (Basic) ranged from a high of -$1.91 in FY2020 and a low of -$2.55 during FY2021.
- Moreover, its 3-year median value for EPS (Basic) was -$2.33 (2022), whereas its average is -$2.26.
- As far as peak fluctuations go, Cellectis' EPS (Basic) spiked by 30.58% in 2018, and later crashed by 33.51% in 2021.
- Yearly analysis of 5 years shows Cellectis' EPS (Basic) stood at -$1.93 in 2018, then dropped by 24.67% to -$2.41 in 2019, then grew by 20.62% to -$1.91 in 2020, then plummeted by 33.51% to -$2.55 in 2021, then increased by 8.63% to -$2.33 in 2022.